Immuno-Oncology at the Crossroads: Confronting Challenges in the Quest for Effective Cancer Therapies
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26136177 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Claudiu Natanael Roznovan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, 030018 Bucharest, Romania. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Medical Oncology. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 257 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Immuno-oncology has rapidly evolved into a cornerstone of modern cancer therapy, offering promising avenues for durable responses and personalized treatment strategies. This narrative review provides a thorough overview of the mechanisms underlying tumor–immune system interactions and the therapeutic innovations emerging from this knowledge. Central to this discussion is the tumor microenvironment (TME), a complex ecosystem of immune and stromal cells that supports tumor growth and shapes therapeutic outcomes. Key cellular and molecular factors within the TME are examined, along with diverse immune escape strategies. We further analyze the landscape of immunotherapeutic approaches, including immune checkpoint inhibitors, cancer vaccines, adoptive cell therapies such as CAR-T cells, and cytokine-based interventions. This review also addresses the increasing importance of predictive biomarkers in immuno-oncology, particularly in patient stratification, monitoring resistance, and managing immunotherapy-related toxicity. Finally, we explore the emerging role of the microbiome as a modulator of immunotherapy efficacy, shedding light on host–microbe–immune interactions that may influence clinical outcomes. By integrating current biological insights with therapeutic innovation, this review outlines the challenges and opportunities ahead in immuno-oncology and emphasizes the need for translational research and cross-disciplinary collaboration to optimize cancer immunotherapy in the era of precision medicine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Botany and Microbiology, Faculty of Biology, University of Bucharest, 030018 Bucharest, Romania.
- Research Institute of University of Bucharest, 050107 Bucharest, Romania.
- eBio-Hub Centre of Excellence in Bioengineering, National University of Science and Technology Politehnica Bucharest, 060042 Bucharest, Romania.
ORCID-Profile: Luminița Gabriela Măruțescu, Gratiela Gradisteanu Pircalabioru
Zitieren
APA
Roznovan, C. N., Măruțescu, L. G., & Gradisteanu Pircalabioru, G. (2025). Immuno-Oncology at the Crossroads: Confronting Challenges in the Quest for Effective Cancer Therapies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26136177
Vancouver
Roznovan CN, Măruțescu LG, Gradisteanu Pircalabioru G. Immuno-Oncology at the Crossroads: Confronting Challenges in the Quest for Effective Cancer Therapies. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26136177
BibTeX
@article{Roznovan2025,
author = {Roznovan, Claudiu Natanael and Măruțescu, Luminița Gabriela and Gradisteanu Pircalabioru, Gratiela},
title = {Immuno-Oncology at the Crossroads: Confronting Challenges in the Quest for Effective Cancer Therapies},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26136177}
}
EUVIMED